Merck & Co
Emerging markets key for Merck’s long-term performance
May 13, 2010Research and Development, Sales and Marketing Merck & Co, em
Merck & Co has highlighted emerging markets such as China and Latin America as a major driver for its success …
Merck gains rights to cancer treatment
May 10, 2010Research and Development Ariad Pharmaceuticals, Merck & Co, NSCLC
Merck has acquired an exclusive license for a new cancer drug that’s in trials for a number of different forms …
Pharma manufacturing news in brief
May 10, 2010Manufacturing and Production American Peptide, DSM Biologics, Dutch CMO SynCo Bio Partners, KV Pharmaceutical, Merck & Co, manufacturing
This week’s round-up of pharmaceutical manufacturing news includes facility updates from KV Pharmaceutical, DSM Biologics, Merck & Co and American …
Merck separates president role, appoints Kenneth Frazier
April 30, 2010Manufacturing and Production, Research and Development, Sales and Marketing Merck & Co, appointment, manufacturing and production, research and development, sales and marketing
Merck & Co has partially split the joint roles of chairman, chief executive and president currently held by Richard Clark, …
Nycomed partners with Merck on Daxas
April 26, 2010Sales and Marketing Daxas, Merck & Co, Nycomed
Swiss firm Nycomed and Merck & Co have agreed to co-promote oral chronic obstructive pulmonary disease candidate Daxas in Europe. …
Merck appoints UK leadership team
January 26, 2010MSD, Merck & Co, appointment
Merck & Co’s UK business has unveiled its new leadership team, following last year’s merger with Schering-Plough. Merck Sharp & …
Dr Michael Rosenblatt appointed chief medical officer Merck
December 21, 2009Research and Development, Sales and Marketing Dr Michael Rosenblatt, Merck & Co, appointment, appointments, research and development, sales and marketing
Merck & Co. appoints Dr Michael Rosenblatt executive VP and chief medical officer. He will be the company’s primary voice …
Merck buys Avecia to boost biomanufacturing
December 21, 2009Manufacturing and Production, Research and Development Avecia Biologics, Cobra, Merck & Co, Recipharm
Merck & Co has bolstered its capabilities in biologics production with the acquisition of contract manufacturer Avecia Biologics. The deal …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
